Pharma
NewsBY
- Feds looking to find $15.8-billion in savings through 'Refocus Government Spending' initiative as pressure mounts for Canada to boost defence spending.
NewsBY
- Feds looking to find $15.8-billion in savings through 'Refocus Government Spending' initiative as pressure mounts for Canada to boost defence spending.
- With a current 'hodgepodge' of bills before Parliament, the Liberals may want to form a cohesive narrative through their fall legislative agenda, says Yaroslav
- With a current 'hodgepodge' of bills before Parliament, the Liberals may want to form a cohesive narrative through their fall legislative agenda, says Yaroslav
- With a current 'hodgepodge' of bills before Parliament, the Liberals may want to form a cohesive narrative through their fall legislative agenda, says Yaroslav
- Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.
- Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.
- Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.
- The big news in health care these days is national pharmacare. This is surely welcome news for those of us living with any chronic
- The big news in health care these days is national pharmacare. This is surely welcome news for those of us living with any chronic
- The big news in health care these days is national pharmacare. This is surely welcome news for those of us living with any chronic
- Focusing on a list of the most commonly prescribed clinically-important drugs could save billions of dollars, both directly in terms of drug budget, and
- Focusing on a list of the most commonly prescribed clinically-important drugs could save billions of dollars, both directly in terms of drug budget, and
- Focusing on a list of the most commonly prescribed clinically-important drugs could save billions of dollars, both directly in terms of drug budget, and
- Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients.
- Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients.
- Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients.
- Green Party Leader Elizabeth May and NDP Leader Jagmeet Singh have done their part as responsible opposition critics on this policy. Now it’s Pierre
- Green Party Leader Elizabeth May and NDP Leader Jagmeet Singh have done their part as responsible opposition critics on this policy. Now it’s Pierre
- Green Party Leader Elizabeth May and NDP Leader Jagmeet Singh have done their part as responsible opposition critics on this policy. Now it’s Pierre
- Canadians have the chance to consider whether to view access to medicines as a pillar of healthcare, or simply an add-on service.
- Canadians have the chance to consider whether to view access to medicines as a pillar of healthcare, or simply an add-on service.
- Canadians have the chance to consider whether to view access to medicines as a pillar of healthcare, or simply an add-on service.
- Re: “First phase of pharmacare must not ‘create new gaps’ in existing coverage, says lobbyists (The Hill Times, April 1). I strongly endorse the
Opinion | April 8, 2024
Opinion | April 8, 2024
- Re: “First phase of pharmacare must not ‘create new gaps’ in existing coverage, says lobbyists (The Hill Times, April 1). I strongly endorse the
Opinion | April 8, 2024
- Re: “First phase of pharmacare must not ‘create new gaps’ in existing coverage, says lobbyists (The Hill Times, April 1). I strongly endorse the
- Using insulin is always challenging, so access to a broad range of appropriate options is vital.
- Using insulin is always challenging, so access to a broad range of appropriate options is vital.
- Using insulin is always challenging, so access to a broad range of appropriate options is vital.
- Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.
- Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.
- Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.
- The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.
- The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.
- The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.
- The government will likely need to borrow to finance any new spending and add more debt, which will result in higher taxes in the
- The government will likely need to borrow to finance any new spending and add more debt, which will result in higher taxes in the
- The government will likely need to borrow to finance any new spending and add more debt, which will result in higher taxes in the
- Florida’s plan is designed to relieve pressure on an already overburdened government health-care system, and will bring tens, if not hundreds, of millions of
- Florida’s plan is designed to relieve pressure on an already overburdened government health-care system, and will bring tens, if not hundreds, of millions of
- Florida’s plan is designed to relieve pressure on an already overburdened government health-care system, and will bring tens, if not hundreds, of millions of
- The FDA’s Florida decision might wind up limiting Canadians’ access to pharmaceutical medicines as long as Canadian drug prices remain well below prices in
- The FDA’s Florida decision might wind up limiting Canadians’ access to pharmaceutical medicines as long as Canadian drug prices remain well below prices in
- The FDA’s Florida decision might wind up limiting Canadians’ access to pharmaceutical medicines as long as Canadian drug prices remain well below prices in
- Pharmacare and Bill C-234, an act to amend the Greenhouse Gas Pollution Pricing Act, are likely to be top issues for government relations this
- Pharmacare and Bill C-234, an act to amend the Greenhouse Gas Pollution Pricing Act, are likely to be top issues for government relations this
- Pharmacare and Bill C-234, an act to amend the Greenhouse Gas Pollution Pricing Act, are likely to be top issues for government relations this
- A public pharmacare program that provides coverage for all Canadians, regardless of age, occupation, or income, would alleviate financial burdens and allow people to
- A public pharmacare program that provides coverage for all Canadians, regardless of age, occupation, or income, would alleviate financial burdens and allow people to
- A public pharmacare program that provides coverage for all Canadians, regardless of age, occupation, or income, would alleviate financial burdens and allow people to
- If we want politicians to know what’s important, we need to make sure that they hear answers to questions that get at the heart
- If we want politicians to know what’s important, we need to make sure that they hear answers to questions that get at the heart
- If we want politicians to know what’s important, we need to make sure that they hear answers to questions that get at the heart
